1 Grysiewicz RA, et al. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin. 2008;26(4):871–95.
2 Slezak A, et al. Transiente ischämische Attacke (TIA) – ein Notfall! Schweiz Med Forum. 2014;14(16–17):333–38.
3 Amarenco P, et al. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke. N Engl J Med. 2016;374(16):1533–42.
4 Emberson J, et al. Effect of treatment delay, age and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomized trials. Lancet. 2014;384(9958):1929–35.
5 Kernan WN, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association / American Stroke Association. Stroke. 2014;45(7):2160–236.
6 Amarenco P, et al. High-Dose Atorvastatin after Stroke or Transient Ischemic Attack. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. N Engl J Med. 2006;355(6):549–59.